Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Transactions in relation to share buyback program

Posted on: 26 Jun 15

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on market abuse and the delegated regulation (EU) no. 2016/1052 of 8 March 2016, also referred to as the Safe Harbor rules (company announcement no. 20 of May 4, 2017). 

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program. Under the share buyback program, which is running from May 4, 2017 and ending no later than March 12, 2018, GN intends to buy back shares for an amount of up to DKK 1,000 million.

The following transactions have been made under the program in the period May 16, 2017 - May 22, 2017: 


  No. of shares Average purchase price, DKK Transaction Value, DKK
   May 16, 2017 29,200 196.42 5,735,458
   May 17, 2017 50,000 193.81 9,690,360
   May 18, 2017 17,055 192.88 3,289,524
   May 19, 2017 20,000 195.08 3,901,570
   May 22, 2017 25,000 195.00 4,875,103
Accumulated under the program 327,255 193.34 63,272,606


Following the above transactions GN owns a total of 6,283,628 own shares corresponding to 4.3% of the company’s total share capital. Every Tuesday, GN will announce the number and value of repurchased shares in company announcements to Nasdaq Copenhagen.

In addition, reference is made to company announcement no. 25 of May 23, 2017 regarding announcement of the placement of an offering (the “Offering”) of convertible bonds consisting of bond with warrant units (the “Units”). As a result of this announcement, and conditional upon settlement of the proposed issue of the Units, the total number of shares held in Treasury at the time of launch of the Offering, 6,215,744, acquired under Safe Harbor programs will not, as initially intended, be used to hedge future obligations of the long-term incentive program and reduce the company’s share capital. Those Shares will instead be kept to hedge future obligations of the intended Units issue. The ongoing share buyback program will continue under the Safe Harbor rules, and the shares bought back going forward as part of the program will consequently be used to hedge the future obligations of the long-term incentive program as well as to reduce the company’s share capital.

For further information please contact:

Peter Justesen
VP – Investor Relations & Treasury
GN Store Nord A/S
Tel: +45 45 75 87 16


Last updated on: 24/05/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.